Tumor Biology

, Volume 37, Issue 1, pp 653–659 | Cite as

Inhibition of autophagy by bafilomycin A1 promotes chemosensitivity of gastric cancer cells

  • Liang-qing Li
  • Wen-jun Xie
  • Dun Pan
  • Hui Chen
  • Lin Zhang
Original Article


Autophagy is an intracellular degradation pathway that delivers organelles or protein to the lysosome and has been recently implicated in the resistance of gastric cancer to chemotherapy. This study aimed to investigate whether blocking autophagy is a new approach for the treatment of chemoresistant gastric cancer. SGC-7901 gastric cancer cell line was treated with 5-fluorouracil (5-FU) or/and autophagy inhibitor bafilomycin A1. Cell viability and growth were evaluated by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) and clonogenic assay. Apoptosis was evaluated by flow cytometry. Cell migratory and invasive ability were evaluated by migration and invasion assays. Autophagy was evaluated by scanning electron microscopic, acridine orange staining, and Western blot analysis. We observed that 5-FU induced autophagy in SGC-7901 cells. Bafilomycin A1 decreased the viability and clone formation, inhibited the invasive and migratory ability, and increased the apoptosis of SGC-7901 cells. Taken together, our data suggest that chemotherapy-induced autophagy contributes to gastric cancer chemoresistance, and the inhibition of autophagy is a promising strategy for gastric cancer therapy.


Bafilomycin A1 Chemoresistance Autophagy Gastric cancer 



This study was supported by the National Key Clinical Specialist Construction Programs of China.

Conflicts of interest



  1. 1.
    Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Bang YJ, Van Gutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA): a phase 3, open-label, randomized controlled trial. Lancet. 2010;376:687–97.CrossRefPubMedGoogle Scholar
  3. 3.
    Mizushima N. The pleiotropic role of autophagy: from protein metabolism to bactericide. Cell Death Differ. 2005;12:1535–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Tsuchihara K, Fujii S, Esumi H. Autophagy and cancer: dynamism of the metabolism of tumor cells and tissues. Cancer Lett. 2009;278:130–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Ito H, Daido S, Kanzawa T, Kondo S, et al. Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol. 2005;26:1401–10.PubMedGoogle Scholar
  6. 6.
    Yu M, Gou WF, Zhao S, et al. Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol. 2013;4:1071–83.CrossRefGoogle Scholar
  7. 7.
    Xu L, Qu XJ, Liu YP, et al. Protective autophagy antagonizes oxaliplatin-induced apoptosis in gastric cancer cells. Chin J Cancer. 2011;30:490–6.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kawai A, Uchiyama H, Takano S, et al. Autophagosome-lysosome fusion depends on the pH in acidic compartments in CHO cells. Autophagy. 2007;3:154–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Wu S, Wang X, Chen J, Chen Y. Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. Biochem Biophys Res Commun. 2013;434:898–903.CrossRefPubMedGoogle Scholar
  10. 10.
    Greene LM, Nolan DP, Regan-Komito D, et al. Inhibition of late-stage autophagy synergistically enhances pyrrolo-1,5-benzoxazepine-6-induced apoptotic cell death in human colon cancer cells. Int J Oncol. 2013;43:927–35.PubMedGoogle Scholar
  11. 11.
    Michel V, Licon-Munoz Y, Trujillo K, et al. Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion. Int J Cancer. 2013;132:1–10.CrossRefGoogle Scholar
  12. 12.
    Luo S, Rubinsztein DC. Apoptosis blocks beelin l-dependent autophagosome synthesis: an effect rescued by Bel-xL. Cell Death Differ. 2010;17:268–77.CrossRefPubMedGoogle Scholar
  13. 13.
    Kim YS, Shin JH, Bae MK, et al. Autophagy activity in pulmonary metastatic tumor tissues from colorectal cancer: a pilot study. Yonsei Med J. 2014;55:1484–8.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Cui J, Hu YF, Feng XM, Tian T, Guo YH, Ma JW, et al. EGFR inhibitors and autophagy in cancer treatment. Tumour Biol. 2014;35:11701–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie. 2008;90:313–23.CrossRefPubMedGoogle Scholar
  16. 16.
    Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Moscat J, Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis and cancer. Cell. 2009;137:1001–4.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8:445–544.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Liang-qing Li
    • 1
  • Wen-jun Xie
    • 1
  • Dun Pan
    • 1
  • Hui Chen
    • 1
  • Lin Zhang
    • 1
  1. 1.Department of Gastrointestinal SurgeryThe First Affiliated Hospital of Fujian Medical UniversityFuzhouChina

Personalised recommendations